Martin James Joseph has filed 5 insider transactions across 1 company since July 2023.
Most recent transaction: a grant/award of 49229 shares of Cocrystal Pharma, Inc. ($COCP) on January 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 9, 2026 | Cocrystal Pharma, Inc. | $COCP | Martin James Joseph | Co-CEO and CFO | A | Stock Options (Right to Buy) | 49229 | $0.00 | 49,229.0000 | 13,784,065 | 9999.99% | 0.36% |
| Oct. 28, 2025 | Cocrystal Pharma, Inc. | $COCP | Martin James Joseph | Co-CEO and CFO | A | Common Stock | 3598 | $1.39 | 44,167.0000 | 10,173,790 | 8.87% | 0.04% |
| Oct. 28, 2025 | Cocrystal Pharma, Inc. | $COCP | Martin James Joseph | Co-CEO and CFO | A | Warrants | 7196 | $1.39 | 7,196.0000 | 10,173,790 | 9999.99% | 0.07% |
| Oct. 9, 2024 | Cocrystal Pharma, Inc. | $COCP | Martin James Joseph | Co-CEO and CFO | A | Common Stock | 40000 | $0.00 | 40,569.0000 | 0 | 7029.88% | 0.00% |
| July 18, 2023 | Cocrystal Pharma, Inc. | $COCP | Martin James Joseph | Co-CEO and CFO | A | Stock Options (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |